Atlas Trials

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Clinical trial NCT05957107 · COMPLETED

Trial details

NCT number
NCT05957107
Sponsor
Beijing VDJBio Co., LTD.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2022-05-26
Primary completion
2023-06-02
Enrollment
181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.